Back in 2013, after we wrote a bullish article on Cumberland Pharmaceuticals (NASDAQ:CPIX), a account manager reached out to me. In a successive phone conversation, he asked a doubt (I’m paraphrasing a diction off of memory) that we couldn’t utterly answer: “What are we blank here?” CPIX seemed roughly too good to be true. At […]
Read more »Real tales of cyberattack response and liberation are tough to come by since organizations are demure to share sum for a horde of legitimate reasons, not a slightest of that is a intensity for disastrous financial fallout. However, if we never tell a stories we doom others to blindly travel a path. Better to share […]
Read more »As insurance fraud continues to develop some-more aspects of a crime engage digital technology. In a UK, where a substantial volume of policies are generated by online transactions, most can be schooled about a patron by a inclination used to gain coverage. Device reputation, according to Max Anhoury, clamp boss of Global Partnerships for iovation, […]
Read more »